• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Ab Sciex, Illumina collaborate to create multi-omics cloud-computing environment

Ab Sciex, Illumina collaborate to create multi-omics cloud-computing environment

October 6, 2014
CenterWatch Staff

Ab Sciex, a Framingham, Mass.-based global provider of mass spectrometry products, and San Diego, Calif.-based Illumina, a global provider of sequencing and array-based technologies, have announced the OneOmics project, an exclusive partnership to bring together SWATH-based next-generation proteomics (NGP) and next-generation sequencing (NGS) tools in a cloud computing environment.

The Ab Sciex SWATH Proteomics Cloud Tool Kit suite of applications will be hosted in BaseSpace, Illumina's applications store and cloud-based informatics community dedicated to advancing genomic analysis. This partnership enables BaseSpace as a single location for genomics and proteomics "big data." With fast, secure and streamlined analysis of complex multi-omics data sets, this solution will help advance biomarker discovery and aid research into diseases such as cancer, diabetes, Alzheimer's and heart disease.

"The integration of proteomic and genomic data analysis through a partnership with Ab Sciex and Illumina is an exciting collaboration that will bring democratization of computational efforts, general access, standardization of data analysis and provide a platform for systems biology in life sciences," said Leroy Hood, president of the Institute for System Biology.

The patented Ab Sciex SWATH Proteomics software solves the "missing data problem" wherein traditional "shotgun" proteomics measures an incomplete set of proteins that are difficult to reproduce. SWATH makes reproducible proteome research feasible for the first time across many samples and is further enhanced through integration with Illumina NGS technologies.

"SWATH software is a patented innovation that allows thousands of proteins to be examined at once with almost no method development, and now with our cloud-based applications customers can process data 50 times faster," said Rainer Blair, president of Ab Sciex. "The OneOmics project will enable better outcomes in omics research. We have developed four SWATH apps to support processing, analyzing and visualization of proteomics mass spec data to extract biological insights."

As NGP and NGS generate ever-increasing volumes of data, this partnership addresses a bottleneck in biomedical research by helping to securely store, retrieve and manage large-scale, complex data sets, and visualize them in a biological context.

Ruedi Aebersold, Ph.D., professor at the Institute of Molecular Biology at the ETH in Zurich, said, "Using this platform, researchers will be able to make predictable, actionable and testable models of disease more quickly and efficiently. In essence it moves the focus of multilevel analysis of biological systems from wet-lab data acquisition into the computational domain, where large data sets can be shared globally.”

"These new proteomics tools add systems biology capabilities to BaseSpace, creating an easy-to-use, cloud-based environment that enables rapid data analysis for a growing range of applications," said Nicholas Naclerio, senior vice president, corporate development and general manager, enterprise informatics for Illumina. "Now, BaseSpace is making informatics accessible to anyone searching for a truly interdisciplinary, systems-level understanding of biology."

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing